Some case reports involved MCAS patients who took the standard dose to lose weight and experienced other kinds of relief
Adults pursuing body composition, metabolic refinement, and overall wellness without the side-effect profile or scale-chasing posture of standard GLP-1 dosing
FIGURE 4 4 Comparative overview of mainstream GLP-1RAs Over the past 2 decades, several GLP-1RAs have entered clinical practice, including short-acting exenatide, intermediate-acting liraglutide, and long-acting formulations such as dulaglutide and semaglutide, as well as the newer dual agonist tirzepatide
In this case, for my 1mg injection, I would withdraw .1ml (10 units on the syringe) for each shot
Some employers have begun to include obesity medications as part of wellness initiatives, recognizing their potential to reduce long-term healthcare costs